LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data
(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.
Read moreFri, 10th Jul 2020 10:15
(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.
Read more(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.
Read more(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.
Read more(Alliance News) - Genedrive PLC shares fell on Friday, after it said it has received a GBP800,000 research and development tax credit.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).
Read more(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.
Read more(Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.
Read moreGenedrive PLC - Manchester, England-based molecular diagnostics company - Draws down GBP600,000 on its GBP5 million equity prepayment facility. In March last year, Genedrive agreed the GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd. At the time it said that proceeds would be used towards the commercialisation of the antibiotic-induced hearing loss test, Genedrive MT-RNR1 ID Kit, and enhancing the Genedrive platform as well as providing additional working capital.
Read moreMonday 25 December | |
no events scheduled | |
Tuesday 26 December | |
no events scheduled | |
Wednesday 27 December | |
Tremor International Ltd | AGM |
Thursday 28 December | |
ADVFN PLC | AGM |
Altona Rare Earths PLC | AGM |
Beximco Pharmaceuticals Ltd | AGM |
Global Petroleum Ltd | AGM |
Visum Technologies PLC | AGM |
Friday 29 December | |
Apollon Formularies PLC | AGM |
Eco Atlantic Oil & Gas Ltd | AGM |
Genedrive PLC | AGM |
Goldplat PLC | AGM |
Lansdowne Oil & Gas PLC | GM re capital raise |
Marula Mining PLC | AGM |
Microsaic Systems PLC | GM re fundraise |
Online Blockchain PLC | AGM |
Secure Property Development & Investment PLC | AGM |
SkinBioTherapeutics PLC | AGM |
Tetragon Financial Group Ltd | AGM |
Woodbois Ltd | AGM |
Zambeef Products PLC | AGM |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive has received its first orders for Genedrive MT-RNR1 products from several countries, it announced on Wednesday, including France, Austria, Greece, Saudi Arabia, Turkey, and the Netherlands.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read more